Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
Mikaël Mazighi, Martin Köhrmann, Robin Lemmens, Philippe Lyrer, Carlos A. Molina, Sébastien Richard, Danilo Toni, Yannick Plétan, Anouar Sari, Adeline Meilhoc, Martine Jandrot‐Perrus, Sophie Binay, Gilles Avenard, Andrea Comenducci, Jean‐Marie Grouin, James C. Grotta, Jean François Albucher, Angelika Alonso, Jörg Berrouschot, Charlotte Cordonnier, Sylvie De Raedt, Philippe Desfontaines, Émilie Doche, Dimitri Hemelsoet, Francisco Macian-Montoro, Jaime Masjuán, Michaël Obadia, André Peeters, Johann Pelz, Peggy Reiner, Tomás Segura, Joaquı́n Serena, Igor Sibon, José Ignacio Tembl, Stéphane Vannier, Mathieu Zuber
Topics & Concepts
PlaceboIschaemic strokeMedicineDouble blindStroke (engine)PlateletInternal medicinePhysical medicine and rehabilitationPhysical therapyIschemiaAlternative medicinePathologyPhysicsThermodynamicsAcute Ischemic Stroke ManagementPlatelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases